Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Clinical trial NCT01246076 · COMPLETED

Trial details

NCT number: NCT01246076
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2011-06-01
Primary completion: 2014-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.